IX Biopharma seeks SGX-ST trading halt lift for shares in Singapore
Reuters2026/09/06 23:31- IX Biopharma submitted a request to lift its trading halt on the SGX-ST.
- The halt covered IX Biopharma Ltd. (ISIN SG1BD9000009; stock code 42C) and related securities on SGX-ST.
- The request took effect at 8:30 a.m. Singapore time on Sept. 7, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The first major "exam" after the Cook era! Morgan Stanley: Apple's (AAPL.US) autumn launch event is the most important in ten years; the first foldable iPhone may spark a new wave of growth
Morgan Stanley analysts stated that Apple's upcoming "Surprise and Shine" autumn product launch event on September 9 may become the company's most important product release in nearly a decade.
10-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - Germany vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
